Maturation of the Gag core decreases the stability of retroviral lipid membranes

Virology

Volumn 433, Issue 2, 2012, Pages 401-409

  Davidoff, Candice ^a   Payne, Riley J ^a   Willis, Sharon H ^a   Doranz, Benjamin J ^a   Rucker, Joseph B ^a  

^a Integral Molecular Inc   (United States)

Author keywords

Biosensor; Detergent; Lipoparticle; Maturation; Viral membrane; Virus stability; Virus like particle

Indexed keywords

CORE PROTEIN; DETERGENT; EMPIGEN; GAG PROTEIN; LUBROL; POLYSORBATE 20; POLYSORBATE 80; SAPONIN; TRITON X 100; UNCLASSIFIED DRUG;

ARTICLE; BIOSENSOR; CONTROLLED STUDY; LIPID BILAYER; MEMBRANE STABILIZATION; MURINE LEUKEMIA VIRUS; NONHUMAN; PRIORITY JOURNAL; PROTEIN PROCESSING; PROTEIN STRUCTURE; RETROVIRUS; VIRUS LIKE AGENT;

ANIMALS; BIOPHYSICAL PHENOMENA; BIOSENSING TECHNIQUES; DETERGENTS; GENE PRODUCTS, GAG; HEK293 CELLS; HUMANS; LEUKEMIA VIRUS, MURINE; LIPID BILAYERS; MEMBRANE LIPIDS; MICE; OCTOXYNOL; PROTEIN PROCESSING, POST-TRANSLATIONAL; VIRUS RELEASE;

MURINE LEUKEMIA VIRUS;

EID: 84867219996     PISSN: 00426822     EISSN: 10960341     Source Type: Journal    
DOI: 10.1016/j.virol.2012.08.023     Document Type: Article

References (68)

1. Aloia R.C., Jensen F.C., Curtain C.C., Mobley P.W., Gordon L.M Lipid composition and fluidity of the human immunodeficiency virus. Proc. Natl. Acad. Sci. U.S.A. 1988, 85(3):900-904.
2. Aloia R.C., Tian H., Jensen F.C. Lipid composition and fluidity of the human immunodeficiency virus envelope and host cell plasma membranes. Proc. Natl. Acad. Sci. U.S.A. 1993, 90(11):5181-5185.
3. Babcock G.J., Mirzabekov T., Wojtowicz W., Sodroski J. Ligand binding characteristics of CXCR4 incorporated into paramagnetic proteoliposomes. J. Biol. Chem. 2001, 276:38433-38440.
4. Babiychuk E.B., Draeger A. Biochemical characterization of detergent-resistant membranes: a systematic approach. Biochem. J. 2006, 397(3):407-416.
5. Balliet J.W., Bates P. Efficient infection mediated by viral receptors incorporated into retroviral particles. J. Virol. 1998, 72(1):671-676.
6. Briggs J.A., Grunewald K., Glass B., Forster F., Krausslich H.G., Fuller S.D. The mechanism of HIV-1 core assembly: insights from three-dimensional reconstructions of authentic virions. Structure 2006, 14(1):15-20.
7. Briggs J.A., Johnson M.C., Simon M.N., Fuller S.D., Vogt V.M. Cryo-electron microscopy reveals conserved and divergent features of gag packing in immature particles of Rous sarcoma virus and human immunodeficiency virus. J. Mol. Biol. 2006, 355(1):157-168.
8. Brown D.A., Rose J.K. Sorting of GPI-anchored proteins to glycolipid-enriched membrane subdomains during transport to the apical cell surface. Cell 1992, 68(3):533-544.
9. Brugger B., Glass B., Haberkant P., Leibrecht I., Wieland F.T., Krausslich H.G. The HIV lipidome: a raft with an unusual composition. Proc. Natl. Acad. Sci. U.S.A. 2006, 103(8):2641-2646.
10. Cadd T.L., Skoging U., Liljestrom P. Budding of enveloped viruses from the plasma membrane. Bioessays 1997, 19(11):993-1000.
11. Canziani G., Zhang W., Cines D., Rux A., Willis S., Cohen G., Eisenberg R., Chaiken I. Exploring biomolecular recognition using optical biosensors. Methods 1999, 19:253-269.
12. Chamberlain L.H. Detergents as tools for the purification and classification of lipid rafts. FEBS Lett. 2004, 559(1-3):1-5.
13. Chernomordik L., Leikina E., Cho M.S., Zimmerberg J. Control of baculovirus gp64-induced syncytium formation by membrane lipid composition. J. Virol. 1995, 69(5):3049-3058.
14. Dalton A.K., Ako-Adjei D., Murray P.S., Murray D., Vogt V.M. Electrostatic interactions drive membrane association of the human immunodeficiency virus type 1 Gag MA domain. J. Virol. 2007, 81(12):6434-6445.
15. de Foresta B., le Maire M., Orlowski S., Champeil P., Lund S., Moller J.V., Michelangeli F., Lee A.G. Membrane solubilization by detergent: use of brominated phospholipids to evaluate the detergent-induced changes in Ca2+-ATPase/lipid interaction. Biochemistry 1989, 28(6):2558-2567.
16. De Tkaczevski L., De Harven E., Friend C. Structure and leukemogenic activity of a murine leukemia virus. J. Virol. 1968, 2(4):365-375.
17. Dick E.C., Jennings L.C., Mink K.A., Wartgow C.D., Inhorn S.L. Aerosol transmission of rhinovirus colds. J. Infect. Dis. 1987, 156(3):442-448.
18. Endres M.J., Clapham P.R., Marsh M., Ahuja M., Turner J.D., McKnight A., Thomas J.F., Stoebenau-Haggarty B., Choe S., Vance P.J., Wells T.N., Power C.A., Sutterwala S.S., Doms R.W., Landau N.R., Hoxie J.A. CD4-independent infection by HIV-2 is mediated by fusin/CXCR4. Cell 1996, 87:745-756.
19. Haun J.B., Hammer D.A. Quantifying nanoparticle adhesion mediated by specific molecular interactions. Langmuir 2008, 24(16):8821-8832.
20. Helenius A., Simons K. Solubilization of membranes by detergents. Biochim. Biophys. Acta 1975, 415(1):29-79.
21. Hoffman T.L., Canziani G., Jia L., Rucker J., Doms R.W. A biosensor assay for studying ligand-membrane receptor interactions: binding of antibodies and HIV-1 Env to chemokine receptors. Proc. Natl. Acad. Sci. U.S.A. 2000, 97(21):11215-11220.
22. Horowitz B., Lazo A., Grossberg H., Page G., Lippin A., Swan G. Virus inactivation by solvent/detergent treatment and the manufacture of SD-plasma. Vox Sang. 1998, 74(Suppl 1):203-206.
23. Jennings L.C., Dick E.C. Transmission and control of rhinovirus colds. Eur. J. Epidemiol. 1987, 3(4):327-335.
24. Kol N., Gladnikoff M., Barlam D., Shneck R.Z., Rein A., Rousso I. Mechanical properties of murine leukemia virus particles: effect of maturation. Biophys. J. 2006, 91(2):767-774.
25. Kol N., Shi Y., Tsvitov M., Barlam D., Shneck R.Z., Kay M.S., Rousso I. A stiffness switch in human immunodeficiency virus. Biophys. J. 2007, 92(5):1777-1783.
26. Lindwasser O.W., Resh M.D. Human immunodeficiency virus type 1 Gag contains a dileucine-like motif that regulates association with multivesicular bodies. J. Virol. 2004, 78:6013-6023.
27. Lowen A.C., Mubareka S., Steel J., Palese P. Influenza virus transmission is dependent on relative humidity and temperature. PLoS Pathog. 2007, 3(10):1470-1476.
28. Luftig R.B., Yoshinaka Y. Rauscher leukemia virus populations enriched for "immature" virions contain increased amounts of P70, the gag gene product. J. Virol. 1978, 25(1):416-421.
29. Mettenleiter T.C., Klupp B.G., Granzow H. Herpesvirus assembly: a tale of two membranes. Curr. Opin. Microbiol. 2006, 9(4):423-429.
30. Mukhopadhyay S., Kuhn R.J., Rossmann M.G. A structural perspective of the flavivirus life cycle. Nat. Rev. Microbiol. 2005, 3(1):13-22.
31. Munro S. Lipid rafts: elusive or illusive?. Cell 2003, 115(4):377-388.
32. Murakami T., Ablan S., Freed E.O., Tanaka Y. Regulation of human immunodeficiency virus type 1 Env-mediated membrane fusion by viral protease activity. J. Virol. 2004, 78(2):1026-1031.
33. Nguyen D.H., Hildreth J.E. Evidence for budding of human immunodeficiency virus type 1 selectively from glycolipid-enriched membrane lipid rafts. J. Virol. 2000, 74(7):3264-3272.
34. Ono A., Demirov D., Freed E.O. Relationship between human immunodeficiency virus type 1 Gag multimerization and membrane binding. J. Virol. 2000, 74(11):5142-5150.
35. Ono A., Freed E.O. Plasma membrane rafts play a critical role in HIV-1 assembly and release. Proc. Natl. Acad. Sci. U.S.A. 2001, 98:13925-13930.
36. Ono A., Orenstein J.M., Freed E.O. Role of the Gag matrix domain in targeting human immunodeficiency virus type 1 assembly. J. Virol. 2000, 74(6):2855-2866.
37. Oxford J.S., Potter C.W., McLaren C., Hardy W. Inactivation of influenza and other viruses by a mixture of virucidal compounds. Appl. Microbiol. 1971, 21(4):606-610.
38. Park J., Morrow C.D. Mutations in the protease gene of human immunodeficiency virus type 1 affect release and stability of virus particles. Virology 1993, 194(2):843-850.
39. Pelchen-Matthews A., Kramer B., Marsh M. Infectious HIV-1 assembles in late endosomes in primary macrophages. J. Cell. Biol. 2003, 162:443-455.
40. Pickl W.F., Pimentel-Muinos F.X., Seed B. Lipid rafts and pseudotyping. J. Virol. 2001, 75(15):7175-7183.
41. Pike L.J., Han X., Chung K.N., Gross R.W. Lipid rafts are enriched in arachidonic acid and plasmenylethanolamine and their composition is independent of caveolin-1 expression: a quantitative electrospray ionization/mass spectrometric analysis. Biochemistry 2002, 41(6):2075-2088.
42. Polozov I.V., Bezrukov L., Gawrisch K., Zimmerberg J. Progressive ordering with decreasing temperature of the phospholipids of influenza virus. Nat. Chem. Biol. 2008, 4(4):248-255.
43. Pornillos O., Garrus J.E., Sundquist W.I. Mechanisms of enveloped RNA virus budding. Trends Cell. Biol. 2002, 12(12):569-579.
44. Roberts P. Resistance of vaccinia virus to inactivation by solvent/detergent treatment of blood products. Biologicals 2000, 28(1):29-32.
45. Roden R.B., Lowy D.R., Schiller J.T. Papillomavirus is resistant to desiccation. J. Infect. Dis. 1997, 176(4):1076-1079.
46. Roper K., Corbeil D., Huttner W.B. Retention of prominin in microvilli reveals distinct cholesterol-based lipid micro-domains in the apical plasma membrane. Nat. Cell. Biol. 2000, 2(9):582-592.
47. Rucker J. Optical biosensor assay using retroviral receptor pseudotypes. Methods Mol. Biol. 2003, 228:317-328.
48. Schuck S., Honsho M., Ekroos K., Shevchenko A., Simons K. Resistance of cell membranes to different detergents. Proc. Natl. Acad. Sci. U.S.A. 2003, 100(10):5795-5800.
49. Segura M.M., Garnier A., Di Falco M.R., Whissell G., Meneses-Acosta A., Arcand N., Kamen A. Identification of host proteins associated with retroviral vector particles by proteomic analysis of highly purified vector preparations. J. Virol. 2008, 82(3):1107-1117.
50. Seitz H., Blumel J., Schmidt I., Willkommen H., Lower J. Comparable virus inactivation by bovine or vegetable derived Tween 80 during solvent/detergent treatment. Biologicals 2002, 30(3):197-205.
51. Sene C., Bout A., Imler J.L., Schultz H., Willemot J.M., Hennebel V., Zurcher C., Valerio D., Lamy D., Pavirani A. Aerosol-mediated delivery of recombinant adenovirus to the airways of nonhuman primates. Hum. Gene Ther. 1995, 6(12):1587-1593.
52. Sherer N.M., Lehmann M.J., Jimenez-Soto L.F., Ingmundson A., Horner S.M., Cicchetti G., Allen P.G., Pypaert M., Cunningham J.M., Mothes W. Visualization of retroviral replication in living cells reveals budding into multivesicular bodies. Traffic 2003, 4:785-801.
53. Soneoka Y., Cannon P.M., Ramsdale E.E., Griffiths J.C., Romano G., Kingsman S.M., Kingsman A.J. A transient three-plasmid expression system for the production of high titer retroviral vectors. Nucleic Acids Res. 1995, 23(4):628-633.
54. Spearman P., Horton R., Ratner L., Kuli-Zade I. Membrane binding of human immunodeficiency virus type 1 matrix protein in vivo supports a conformational myristyl switch mechanism. J. Virol. 1997, 71(9):6582-6592.
55. St Vincent M.R., Colpitts C.C., Ustinov A.V., Muqadas M., Joyce M.A., Barsby N.L., Epand R.F., Epand R.M., Khramyshev S.A., Valueva O.A., Korshun V.A., Tyrrell D.L., Schang L.M. Rigid amphipathic fusion inhibitors, small molecule antiviral compounds against enveloped viruses. Proc. Natl. Acad. Sci. U.S.A. 2010, 107:17339-17344.
56. Stewart L., Schatz G., Vogt V.M. Properties of avian retrovirus particles defective in viral protease. J. Virol. 1990, 64(10):5076-5092.
57. Stromberg K. Surface-active agents for isolation of the core component of avian myeloblastosis virus. J. Virol. 1972, 9(4):684-697.
58. Suomalainen M. Lipid rafts and assembly of enveloped viruses. Traffic 2002, 3(10):705-709.
59. Wang S., Shan X., Patel U., Huang X., Lu J., Li J., Tao N. Label-free imaging, detection, and mass measurement of single viruses by surface plasmon resonance. Proc. Natl. Acad. Sci. U.S.A. 2010, 107:16028-16032.
60. Webster R.G., Darlington R.W. Disruption of myxoviruses with Tween 20 and isolation of biologically active hemagglutinin and neuraminidase subunits. J. Virol. 1969, 4(2):182-187.
61. Welker R., Hohenberg H., Tessmer U., Huckhagel C., Krausslich H.G. Biochemical and structural analysis of isolated mature cores of human immunodeficiency virus type 1. J. Virol. 2000, 74(3):1168-1177.
62. Willis S., Davidoff C., Schilling J., Wanless A., Doranz B.J., Rucker J. Virus-like particles as quantitative probes of membrane protein interactions. Biochemistry 2008, 47(27):6988-6990.
63. Wimley W.C., Hristova K. Antimicrobial peptides: successes, challenges and unanswered questions. J. Membr. Biol. 2011, 239(1-2):27-34.
64. Wolf M.C., Freiberg A.N., Zhang T., Akyol-Ataman Z., Grock A., Hong P.W., Li J., Watson N.F., Fang A.Q., Aguilar H.C., Porotto M., Honko A.N., Damoiseaux R., Miller J.P., Woodson S.E., Chantasirivisal S., Fontanes V., Negrete O.A., Krogstad P., Dasgupta A., Moscona A., Hensley L.E., Whelan S.P., Faull K.F., Holbrook M.R., Jung M.E., Lee B. A broad-spectrum antiviral targeting entry of enveloped viruses. Proc. Natl. Acad. Sci. U.S.A. 2010, 107:3157-3162.
65. Yeager M., Wilson-Kubalek E.M., Weiner S.G., Brown P.O., Rein A. Supramolecular organization of immature and mature murine leukemia virus revealed by electron cryo-microscopy: implications for retroviral assembly mechanisms. Proc. Natl. Acad. Sci. U.S.A. 1998, 95(13):7299-7304.
66. Yoshinaka Y., Ishigame K., Ohno T., Kageyama S., Shibata K., Luftig R.B. Preparations enriched for "immature" murine leukemia virus particles that remain in tissue culture fluids are deficient in Pr65gag proteolyic activity. Virology 1980, 100(1):130-140.
67. Zanetti G., Briggs J.A., Grunewald K., Sattentau Q.J., Fuller S.D. Cryo-electron tomographic structure of an immunodeficiency virus envelope complex in situ. PLoS Pathog. 2006, 2(8):e83.
68. Zhou W., Resh M.D. Differential membrane binding of the human immunodeficiency virus type 1 matrix protein. J. Virol. 1996, 70(12):8540-8548.